3653 results for «319»
3653 results
TAVI: how to prevent stroke
17 May 2024 – From EuroPCR 2024
This session focuses on strategies for preventing stroke during TAVI procedures. It features case presentations and discussions on the use of cerebral protection devices, including a novel full-body embolic protection device, and the management of complications such as cerebral hyperperfusion syndrome.
Transcatheter solutions for combined valve disease
17 May 2024 – From EuroPCR 2024
This session delves into the transcatheter management of patients with combined valve disease, including cases of concomitant aortic stenosis and mitral regurgitation, failed bioprostheses in both the aortic and mitral valves, and severe aortic regurgitation after previous valve-sparing root replacement. The session features case presentations and...
Non left main bifurcation - LIVE case
17 May 2024 – From EuroPCR 2024
A 53-year-old male presented with a late STEMI one month ago. Coronary angiography revealed three-vessel disease: CX occlusion (culprit lesion), RCA bifurcation stenosis, and severe mid LAD-D1 (1-1-1) stenosis. The operators performed RCA PCI during the STEMI hospitalization.
In this live case, they performed the LAD-D1 bifurcation...
Hot topics in interventional management of out-of-hospital cardiac arrest (OHCA)
17 May 2024 – From EuroPCR 2024
This session explores the latest insights and strategies for managing out-of-hospital cardiac arrest (OHCA) patients. Key topics include identifying OHCA patients who may benefit from immediate cathlab admission, the default PCI strategy in OHCA, and how to organize an effective OHCA network. Discussions will cover estimating...
EAPCI Fellowship Grants Award Ceremony
16 May 2024 – From EuroPCR 2024
This session is the EAPCI Fellowship Grants Award Ceremony, where outstanding individuals will be recognized for their contributions to the field of interventional cardiology.
New evidence on TAVI from PCR Companions
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 abstract submissions presenting the latest evidence on TAVI. Topics include device success in valve-in-valve TAVI, next-day discharge after TAVI, comparative network meta-analysis of PCI strategies in TAVI patients, factors associated with thrombosis treatment response, and outcomes of a novel balloon-expandable...
Andreas Grüntzig Ethica Award ceremony
15 May 2024 – From EuroPCR 2024
This session is the Andreas Grüntzig Ethica Award ceremony.
Imaging and physiology guided PCI
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 clinical case submissions showcasing the use of imaging and physiology guidance during PCI. Cases cover topics such as managing cardiac arrest during PCI, virtual reality-guided PCI, low-contrast PCI in multivessel disease, and the comprehensive assessment of obstructive and non-obstructive coronary...
Primary left ventricular unloading in anterior STEMI without cardiogenic shock: Results from the STEMI-Door to Unload randomized clinical trial
28 Mar 2026
Elad Asher provides his take on the STEMI-DTU trial, which was presented by Navin K. Kapur at the ACC.26 in New Orleans, and simultaneously published in the JACC.
Author
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.
Author
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome
03 Sep 2025
Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
